断裂融合桥循环驱动高瘤基因数量与中度的瘤内异质性
Siavash Raeisi Dehkordi1, Ivy Tsz-Lo Wong2,3, Jing Ni4,5
1Department of Computer Science and Engineering, University of California San Diego, San Diego, CA, USA.
Nature communications
|February 10, 2025
概括
断裂融合桥 (BFB) 循环和染色体外DNA (ecDNA) 通过增加瘤基因拷贝数量来驱动癌症. 我们的新算法OM2BFB检测到BFB放大,揭示了与ecDNA相比不同的生物特征和治疗潜力.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 瘤基因放大对于癌症的发展至关重要.
- 断裂融合桥 (BFB) 循环和染色体外DNA (ecDNA) 是瘤基因放大机制.
- 由于检测困难,BFB放大对癌症的影响仍然不清楚.
研究的目的:
- 引入OM2BFB,一种用于使用光学基因组映射 (OGM) 检测和重建BFB放大的算法.
- 为了比较BFB检测方法,并分析BFB放大生物和临床影响.
主要方法:
- 开发和验证OM2BFB算法用于BFB放大检测.
- 使用光学基因组映射 (OGM) 和全基因组测序 (WGS).
- 对2557种原发性瘤和癌细胞系的分析.
主要成果:
- 在检测BFB放大时,OM2BFB实现了高精度 (>93%) 和回忆 (92%).
- 在各种癌症的371个事件中确定了BFB放大,特别是在宫癌,头癌,肺癌和食道癌中流行.
- 与ecDNA增强基因相比,BFB增强基因表达变异性较低,BFB(+) 瘤表现出减少异质性和延迟耐药性.
结论:
- BFB和ecDNA是具有不同生物特性的独特的瘤基因放大机制.
- OM2BFB提供了一种可靠的方法来检测BFB放大.
- 这些发现表明BFB和ecDNA驱动的癌症有不同的治疗策略.
相关概念视频
Fixing Double-strand Breaks
11.9K
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
11.9K
Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Cancer
47.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.5K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


